When the results of the first-ever platform trial for amyotrophic lateral sclerosis (ALS) were published this February, the headlines might have seemed disappointing: four experimental drugs failed to ...
REDLANDS, Calif.--(BUSINESS WIRE)--The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri, ...
SAN FRANCISCO--(BUSINESS WIRE)--Unlearn ®, a pioneering artificial intelligence company, today announced a groundbreaking partnership with German-based APST Research (APST), a leading platform for ALS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results